All In MedTech

Device Trial Radar · NCT04961398

Evaluation of Heidelberg Engineering SPECTRALIS OCT Signal to Noise Ratio Effect on Parameter Measurements

Last checked: Nov 20, 2026Latest source record: Sep 16, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

9

Actual

Start

Jun 21, 2021

Primary completion

Jun 24, 2021

Study completion Jun 24, 2021

Sponsor

Lead sponsor
Heidelberg Engineering GmbHNot on our public-company list
Sponsor type
Industry
First posted
Jul 14, 2021

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Evaluation of effect of various OCT scan speeds and filters on parameter measurements.

Conditions

  • Normal Eyes

Interventions

  • OCT imagingDevice

    OCT imaging on Normal Eyes without any filter and with various ND filters as per protocol

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Macular layer thicknessesTime frame: during the intervention
  2. Bruch's Membrane Opening (BMO)-Minimum Rim Width (MRW)Time frame: during the intervention
  3. Peripapillary Retinal Nerve Fiber Layer Thickness (RNFLT)Time frame: during the intervention

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Heidelberg Engineering, Inc.

    Franklin, Massachusetts

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.